MedPath

EPINASTINE HYDROCHLORIDE

These highlights do not include all the information needed to use EPINASTINE HYDROCHLORIDE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for EPINASTINE HYDROCHLORIDE OPHTHALMIC SOLUTION. EPINASTINE HYDROCHLORIDE ophthalmic solution Initial U.S. Approval: 2003

Approved
Approval ID

cafe4650-6aa4-4466-9beb-064ee5a0e401

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 24, 2018

Manufacturers
FDA

Sun Pharmaceutical Industries, Inc.

DUNS: 146974886

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

EPINASTINE HYDROCHLORIDE

PRODUCT DETAILS

NDC Product Code62756-329
Application NumberANDA091626
Marketing CategoryC73584
Route of AdministrationOPHTHALMIC
Effective DateOctober 24, 2018
Generic NameEPINASTINE HYDROCHLORIDE

INGREDIENTS (8)

EPINASTINE HYDROCHLORIDEActive
Quantity: 0.5 mg in 1 mL
Code: GFM415S5XL
Classification: ACTIB
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATEInactive
Code: 5QWK665956
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

EPINASTINE HYDROCHLORIDE - FDA Drug Approval Details